Cargando…

Outcomes and Nephrotoxicity Associated with Vancomycin Treatment in Patients 80 Years and Older

PURPOSE: This retrospective observational study investigated the efficacy and safety of vancomycin to treat patients aged 80 years and older. In particular, the associations between vancomycin trough concentration (VTC) and treatment outcomes or nephrotoxicity were explored. PATIENTS AND METHODS: Pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Yunchao, Dai, Ning, Wei, Wei, Jiang, Chunyan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8179733/ https://www.ncbi.nlm.nih.gov/pubmed/34103905 http://dx.doi.org/10.2147/CIA.S308878

Ejemplares similares

Relationship between vancomycin-induced nephrotoxicity and vancomycin trough concentration in older adults: A retrospective observational study
por: Dai, Ning, et al.
Publicado: (2023)

The Nephrotoxicity of Vancomycin
por: Filippone, EJ, et al.
Publicado: (2017)

Vancomycin-Associated Tubular Casts and Vancomycin Nephrotoxicity
por: Tantranont, Ngoentra, et al.
Publicado: (2021)

Vancomycin nephrotoxicity: Vancomycin tubular casts with characteristic electron microscopic findings
por: Tantranont, Ngoentra, et al.
Publicado: (2019)

Utilizing the Patient Care Process to Minimize the Risk of Vancomycin-Associated Nephrotoxicity
por: Selby, Ashley R., et al.
Publicado: (2019)

396 What is the Best Predictor for Vancomycin Nephrotoxicity?
por: Hammoud, Kassem, et al.
Publicado: (2014)

Vitamin E in the prevention of vancomycin-induced nephrotoxicity
por: Soltani, Rasool, et al.
Publicado: (2020)

The influence of vancomycin on renal functions, the predictors and associated factors for nephrotoxicity
por: Altowayan, Waleed M., et al.
Publicado: (2023)

Incidence and Predisposing Factors of Vancomycin-Induced Nephrotoxicity in Children
por: Ragab, Ahmed R., et al.
Publicado: (2013)

Protective Effects of Cilastatin against Vancomycin-Induced Nephrotoxicity
por: Humanes, Blanca, et al.
Publicado: (2015)

Age-dependent changes in vancomycin-induced nephrotoxicity in mice
por: Takigawa, Masaki, et al.
Publicado: (2018)

In Vitro Nephrotoxicity and Permeation of Vancomycin Hydrochloride Loaded Liposomes
por: Papp, Nicole, et al.
Publicado: (2022)

Vancomycin Loading Doses and Nephrotoxicity on Medicine Teaching Services
por: Wagner, Phillip, et al.
Publicado: (2022)

1570. Association Between Vancomycin Area Under the Curve (AUC) and Nephrotoxicity
por: Poston-Blahnik, Anna, et al.
Publicado: (2019)

Vancomycin-induced nephrotoxicity in non-intensive care unit pediatric patients
por: Kwak, Shinhyeung, et al.
Publicado: (2021)

Exposure to Hyperbaric Oxygen Intensified Vancomycin-Induced Nephrotoxicity in Rats
por: Sabler, Itay M., et al.
Publicado: (2016)

1575. Vancomycin Loading Doses and Nephrotoxicity on Medicine Teaching Services
por: Wagner, Phillip, et al.
Publicado: (2019)

A Monocentric Retrospective Study of AUC/MIC Ratio of Vancomycin Associated with Clinical Outcomes and Nephrotoxicity in Patients with Enterococcal Infections
por: Katip, Wasan, et al.
Publicado: (2021)

Comparative Incidence of Nephrotoxicity by Age Group among Adult Patients Receiving Vancomycin
por: Carreno, Joseph J., et al.
Publicado: (2013)

Is Early Monitoring Better? Impact of Early Vancomycin Exposure on Treatment Outcomes and Nephrotoxicity in Patients with Methicillin-Resistant Staphylococcus aureus Infections
por: Chattaweelarp, Thanawat, et al.
Publicado: (2020)

Metabolic and Lipidomic Assessment of Kidney Cells Exposed to Nephrotoxic Vancomycin Dosages
por: Lagies, Simon, et al.
Publicado: (2021)

Presentation, Molecular Characteristics, Treatment, and Outcomes of Colorectal Cancer in Patients Older than 80 Years Old
por: Voutsadakis, Ioannis A.
Publicado: (2023)

Development and Validation of a Risk Prediction Model of Vancomycin‐Associated Nephrotoxicity in Elderly Patients: A Pilot Study
por: Pan, Chen, et al.
Publicado: (2020)

Pharmacokinetic assessment of vancomycin in critically ill patients and nephrotoxicity prediction using individualized pharmacokinetic parameters
por: Ghasemiyeh, Parisa, et al.
Publicado: (2022)

Convalescent plasma treatment for patients of 80 years and older with COVID-19 pneumonia
por: Romon, Iñigo, et al.
Publicado: (2021)

Impact of a vancomycin loading dose on the achievement of target vancomycin exposure in the first 24 h and on the accompanying risk of nephrotoxicity in critically ill patients
por: Hodiamont, C J, et al.
Publicado: (2021)

Long-Term Outcomes of Acute Ischemic Stroke in Patients Aged 80 Years and Older
por: Minn, Yang-Ki, et al.
Publicado: (2008)

Oncologic Outcome and Efficacy of Chemotherapy in Colorectal Cancer Patients Aged 80 Years or Older
por: Liu, Wenting, et al.
Publicado: (2020)

Impact of Area Under the Concentration-Time Curve-Guided Monitoring on Vancomycin Nephrotoxicity and Treatment Outcomes in Methicillin-Resistant Staphylococcus Aureus Bacteremia in Korean Patients
por: Kim, Young Rong, et al.
Publicado: (2022)

Protective Effects of Hydroalcoholic Extract of Rosa canina Fruit on Vancomycin-Induced Nephrotoxicity in Rats
por: Sadeghi, Hossein, et al.
Publicado: (2021)

Combination of Pentoxifylline and Ginko Biloba Nephroprotective Effect in Animal Models with Vancomycin-Induced Nephrotoxicity
por: POPA, ROMEO, et al.
Publicado: (2022)

757 Comparison of Nephrotoxicity in Outpatient Parenteral Antimicrobial Therapy (OPAT) Patients Receiving Beta-lactams or Vancomycin
por: Streifel, Amber, et al.
Publicado: (2014)

The Serum Concentration of Vancomycin as a Diagnostic Predictor of Nephrotoxic Acute Kidney Injury in Critically Ill Patients
por: Zamoner, Welder, et al.
Publicado: (2022)

Use of tiotropium in patients with COPD aged 80 years and older
por: SATOH, HIROAKI, et al.
Publicado: (2013)

Community‐acquired bacterial meningitis in patients of 80 years and older
por: van Soest, Thijs M., et al.
Publicado: (2022)

Treatment at Twilight: An Analysis of Therapy Patterns and Outcomes in Adults 80 Years and Older With Advanced or Metastatic NSCLC
por: Burns, Ethan A., et al.
Publicado: (2023)

Outcome of incisional hernia repair in patients 80 years and older: results from the Herniamed-Registry
por: Mehdizadeh-Shrifi, A., et al.
Publicado: (2023)

Vancomycin-associated nephrotoxicity in non-critically ill patients admitted in a Brazilian public hospital: A prospective cohort study
por: de Almeida, Claudmeire Dias Carneiro, et al.
Publicado: (2019)

Impact of ascorbic acid in reducing the incidence of vancomycin associated nephrotoxicity in critically ill patients: A preliminary randomized controlled trial
por: Hesham El-Sherazy, Nouran, et al.
Publicado: (2021)

1335. A Translational Nephrotoxicity Model to Probe Acute Kidney Injury with Vancomycin and Piperacillin–Tazobactam
por: Pais, Gwendolyn M, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_39ou3g3bamvlrjleigi1uu76pd